Abstract
PurposeTo evaluate in two clinics vision improvement in AMD patients treated with a new corneal elastic modulus‐altering procedure (CPV) for light redirections onto multiple retinal areas.MethodsTen eyes (6 wet, 4 dry), with best‐corrected near and distance visual acuities (CNVA and CDVA) between 20/80 and 20/400, without pathological retinal morphology completely affecting the central 10° (3 mm) on OCT, were given a single treatment of CPV and were examined for 12 months post‐CPV.ResultsLogMAR Mean CNVA and CDVA in treated eyes improved (p < 0.01) from pre‐CPV 0.957 and 0.942 to 0.512 and 0.638, 0.544 and 0.602, 0.531 and 0.672 at 1, 6 and 12 m, respectively. The number of ETDRS letters gained in mean binocular CNVA/CDVA were 22/15, 25/19, 25/18 at 1, 6, and 12 m, respectively. Administered NEI VFQ‐25 at 3 m improved from pre‐CPV. No CPV complications or adverse events occurred.ConclusionsCPV effectively, safely, rapidly and comfortably redirects light onto functional retinal areas after a single treatment to provide, without visual training, significantly improved monocular and binocular near and distance vision without causing peripheral field restriction or diplopia in patients with atrophic or neovascular AMD with poor vision, including after anti‐VEGF therapy to which CPV is complementary and for which CPV may improve compliance because of improved vision restoration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.